AI-generated summary
The authors studied human embryonic stem cell-derived mesenchymal stem cells exposed to low-level blue laser light at 457 nm and doses from 0.5 to 5.0 J/cm². They report increased proliferation, viability, and migration at certain doses, with the strongest osteogenic changes at 2.0 J/cm², and suggest possible clinical use for osteoporosis.
- Who or what was studied
- Human embryonic stem cell-derived mesenchymal stem cells (hESC-MSCs) grown in culture
- Wavelengths
- 457 nm
- Limits stated in the abstract
- The study appears to be an in vitro cell culture study, and the abstract does not report any human or clinical outcomes to support the suggested osteoporosis application.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 457 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.